1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow KeyBioscience AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis KBP-336, Placebo - Osteoarthritis in the Knee, Obesity | Phase 2 | Recruiting | KeyBioscience AG | 600 | 2025-01-28 | 2025-02-19 |
| Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes Daily injection of KBP/placebo for 12 weeks as add-on to metformin - Type 2 Diabetes Mellitus | Phase 2 | Completed | KeyBioscience AG | 255 | 2017-08-23 | 2018-09-11 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Osteoarthritis (1) · Pain (1)
Czechia (2) · Denmark (2) · Moldova (2) · Poland (2) · Romania (2) · Hong Kong (1) · United Kingdom (1)
2017 (1)